Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report

Atsushi Goto; Hiroshi Noto; Mitsuhiko Noda; Kohjiro Ueki; Masato Kasuga; Naoko Tajima; Ken Ohashi; Ryuichi Sakai; Shoichiro Tsugane; Nobuyuki Hamajima; Kazuo Tajima; Kohzoh Imai; Hitoshi Nakagama

doi:10.1007/s13340-016-0257-z

Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report

Diabetol Int. 2016 Mar 7;7(1):12-15. doi: 10.1007/s13340-016-0257-z. eCollection 2016 Mar.

Authors

Atsushi Goto¹, Hiroshi Noto², Mitsuhiko Noda³, Kohjiro Ueki⁴, Masato Kasuga⁵, Naoko Tajima⁶, Ken Ohashi⁷, Ryuichi Sakai⁸, Shoichiro Tsugane⁹, Nobuyuki Hamajima¹⁰, Kazuo Tajima¹¹, Kohzoh Imai¹², Hitoshi Nakagama¹³

Affiliations

¹ 1Tokyo Women's Medical University, Tokyo, Japan.
² 2St. Luke's International Hospital, Tokyo, Japan.
³ 3Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
⁴ 4Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
⁵ 5National Center for Global Health and Medicine, Tokyo, Japan.
⁶ 6Jikei University School of Medicine, Tokyo, Japan.
⁷ 7Department of General Internal Medicine, Dentistry, and Oncologic Emergencies, National Cancer Center Hospital, Tokyo, Japan.
⁸ 8Department of Biochemistry, Kitasato University School of Medicine, Sagamihara, Japan.
⁹ 9National Cancer Center Research Center for Cancer Prevention and Screening, Tokyo, Japan.
¹⁰ 10Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
¹¹ 11Department of Public Health and Occupational Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
¹² 12Center for Antibody and Vaccine Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
¹³ 13National Cancer Center Research Institute, Tokyo, Japan.

Abstract

The Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer published its first report in July 2013 on the epidemiological assessment of the associations of diabetes with cancer risk/prognosis, the common risk factors for diabetes and cancer, and cancer risk associated with diabetes treatment The JDS/JCA Joint Committee continued its work to assess the role of glycemic control in the development of cancer in patients with diabetes. This review shows that high-quality evidence examining the association between glycemic control and cancer risk is lacking.

Keywords: Cancer; Diabetes; Glucose control; HbA1c; Observational studies; Randomized controlled trials.

Publication types

Review